Home
/
PSYCHEMEDICS CORP
/
Financials
/
Quarterly
PSYCHEMEDICS CORP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that PSYCHEMEDICS CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Sep 30, 2018
$11.02M
Oct 25, 2018
Q2
2018
Jun 30, 2018
$10.79M
Jul 27, 2018
Q1
2018
Mar 31, 2018
$10.94M
Apr 26, 2018
Q3
2018
Sep 30, 2017
$10.05M
Oct 25, 2018
Q2
2018
Jun 30, 2017
$9.68M
Jul 27, 2018
Q1
2018
Mar 31, 2017
$10.21M
Apr 26, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
($535.0K)
Nov 12, 2024
Q2
2024
Jun 30, 2024
($827.0K)
Aug 13, 2024
Q1
2024
Mar 31, 2024
($688.0K)
May 14, 2024
Q3
2024
Sep 30, 2023
($2.10M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($726.0K)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($384.0K)
May 14, 2024
Q3
2023
Sep 30, 2022
($97.0K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($338.0K)
Aug 14, 2023
Q1
2023
Mar 31, 2022
$39.0K
May 11, 2023
Q3
2022
Sep 30, 2021
$739.0K
Nov 10, 2022
Q2
2022
Jun 30, 2021
$134.0K
Aug 10, 2022
Q1
2022
Mar 31, 2021
$83.0K
May 11, 2022
Q3
2021
Sep 30, 2020
($1.11M)
Nov 15, 2021
Q3
2020
Jun 30, 2020
($2.05M)
Nov 10, 2020
Q2
2021
Jun 30, 2020
($2.05M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($159.0K)
May 13, 2021
Q3
2020
Mar 31, 2020
($159.0K)
Nov 10, 2020
Q3
2020
Sep 30, 2019
$677.0K
Nov 10, 2020
Q2
2020
Jun 30, 2019
$768.0K
Aug 13, 2020
Q3
2020
Jun 30, 2019
$768.0K
Nov 10, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
($595.0K)
Nov 12, 2024
Q2
2024
Jun 30, 2024
($899.0K)
Aug 13, 2024
Q1
2024
Mar 31, 2024
($567.0K)
May 14, 2024
Q3
2024
Sep 30, 2023
($1.11M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($417.0K)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($528.0K)
May 14, 2024
Q3
2023
Sep 30, 2022
($375.0K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($342.0K)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($10.0K)
May 11, 2023
Q3
2022
Sep 30, 2021
$850.0K
Nov 10, 2022
Q2
2022
Jun 30, 2021
$207.0K
Aug 10, 2022
Q1
2022
Mar 31, 2021
$117.0K
May 11, 2022
Q3
2021
Sep 30, 2020
($1.41M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($3.31M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($242.0K)
May 13, 2021
Q3
2020
Sep 30, 2019
$1.33M
Nov 10, 2020
Q2
2020
Jun 30, 2019
$1.33M
Aug 13, 2020
Q1
2020
Mar 31, 2019
$944.0K
May 15, 2020
Q3
2019
Sep 30, 2018
$2.12M
Oct 24, 2019
Q2
2019
Jun 30, 2018
$2.06M
Jul 24, 2019